Ekso Bionics Holdings Inc. won FDA clearance to treat patients with hemiplegia due to stroke, with its exoskeleton. The clearance could give the Richmond, Calif.-based firm greater penetration in the rehabilitation center market. Ekso's strategy differs from competitors in the space, which are focused on home and community use for the devices.